Allakos Inc.
METHODS AND COMPOSITIONS FOR TREATING CHRONIC URTICARIA
Last updated:
Abstract:
The present disclosure provides methods for the treatment of chronic urticaria. In particular, the present disclosure provides methods for the treatment of chronic urticaria through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of chronic urticaria.
Status:
Application
Type:
Utility
Filling date:
3 May 2019
Issue date:
12 Aug 2021